Stock Price, News, Quote and Profile of AMPIO PHARMACEUTICALS INC(NYSEARCA:AMPE) stock

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

AMPIO PHARMACEUTICALS INC

NYSEARCA:AMPE (4/12/2024, 7:04:00 PM)

0.62

-0.09 (-12.91%)

Chartmill TA Rating

Chartmill Setup Rating

Sector

GICS SectorHealth Care

GICS IndustryPharmaceuticals

Chartmill FA Rating

Valuation

Growth

Profitability

Health

Dividend

Overview

Earnings (Last)

Earnings (Next)

Ins Owners

Inst Owners

Market Cap514.60K

PEN/A

Fwd PEN/A

Dividend YieldN/A

Analysts

IPO

Stock Screener Links

American Stock Exchange Stock Screener

Find more stocks on American Stock Exchange

GICS Sector Stock Screener

Find competitors from the same sector on the USA

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

Company Profile

Ampio Pharmaceuticals Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Englewood, Colorado and currently employs 8 full-time employees. The company went IPO on 2011-05-19. Ampio Pharmaceuticals, Inc. is a biopharmaceutical company. The firm is focused on the preclinical development of AR-300, and is conducting studies to evaluate the efficacy of AR-300 in osteoarthritis-related pain. The firm is primarily targeting the clinical development of AR-300 for the treatment of osteoarthritis of the knee (OAK). AR-300 is a small-molecule formulation that has demonstrated anti-inflammatory properties in vitro and protection of cartilage in preclinical rat meniscal tear studies.

Company Info

AMPIO PHARMACEUTICALS INC

9800 Mount Pyramid Court, Suite 400

Englewood COLORADO 80112

P: 17204376500

CEO: Michael Macaluso

Employees: 8

Website: https://ampiopharma.com/

AMPE News

a month ago - InvestorPlaceAMPE Stock Earnings: Ampio Pharmaceuticals Reported Results for Q4 2023

Ampio Pharmaceuticals just reported results for the fourth quarter of 2023.

4 months ago - Seeking AlphaAmpio Pharmaceuticals reaches settlement in principle in certain legal actions (NYSE:AMPE)

Ampio Pharmaceuticals reaches settlements in principle for pending securities fraud class action and derivative actions, with costs covered by D&O...